PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • IMPORTANT DRUG WARNING

    Product: Cometriq (TM) (cabozantinib)
    Posted On: January 16, 2013
    MANUFACTURER: Exelixis, Inc.
    AUDIENCE: Oncology, Endocrinology, Diabetes & Metabolism, Head/Neck Surgeons

    If unable to view, click here to download this file to your computer.